(Q54345809)
Statements
Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease. (English)
Azuma E
Yamamoto H
Kaplan J
1 September 1989
143
5
1524-1529
scientific article